Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response

[1]  M. Byrne,et al.  Knockout of pentraxin 3, a downstream target of growth differentiation factor-9, causes female subfertility. , 2002, Molecular endocrinology.

[2]  C. Montagnoli,et al.  Dendritic Cells Transport Conidia and Hyphae of Aspergillus fumigatus from the Airways to the Draining Lymph Nodes and Initiate Disparate Th Responses to the Fungus1 , 2002, The Journal of Immunology.

[3]  Ruslan Medzhitov,et al.  Toll-like receptors and innate immunity , 2001, Nature Reviews Immunology.

[4]  V. Torri,et al.  Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients , 2001, Critical care medicine.

[5]  M. Martelli,et al.  Defective antifungal T-helper 1 (TH1) immunity in a murine model of allogeneic T-cell-depleted bone marrow transplantation and its restoration by treatment with TH2 cytokine antagonists. , 2001, Blood.

[6]  M. Pepys,et al.  Role of serum amyloid P component in bacterial infection: protection of the host or protection of the pathogen. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[7]  C. Garlanda,et al.  The long pentraxin PTX3 binds to apoptotic cells and regulates their clearance by antigen-presenting dendritic cells. , 2000, Blood.

[8]  A. Mencacci,et al.  Cytokines in candidiasis and aspergillosis. , 2000, Current pharmaceutical biotechnology.

[9]  G Olivetti,et al.  PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans. , 2000, Circulation.

[10]  Pier Paolo Pandolfi,et al.  Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies , 1998, Nature Genetics.

[11]  Francesco Tedesco,et al.  Multimer Formation and Ligand Recognition by the Long Pentraxin PTX3 , 1997, The Journal of Biological Chemistry.

[12]  L. Romani.  The T cell response against fungal infections. , 1997, Current opinion in immunology.

[13]  J. Volanakis,et al.  C-reactive protein , 1997, Immunologic research.

[14]  J. Latgé,et al.  Th1 and Th2 cytokines in mice with invasive aspergillosis , 1997, Infection and immunity.

[15]  T. Blundell,et al.  Cloning of mouse ptx3, a new member of the pentraxin gene family expressed at extrahepatic sites. , 1996, Blood.

[16]  P. Ghezzi,et al.  Pattern of cytokines and pharmacomodulation in sepsis induced by cecal ligation and puncture compared with that induced by endotoxin , 1995, Clinical and diagnostic laboratory immunology.

[17]  G. Peri,et al.  Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes , 1994 .

[18]  J. Vilček,et al.  Relationship of TSG-14 protein to the pentraxin family of major acute phase proteins. , 1994, Journal of immunology.

[19]  A. Whitehead,et al.  The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. , 1994, Immunology today.

[20]  T. Blundell,et al.  Structure of pentameric human serum amyloid P component , 1994, Nature.

[21]  J. Vilček,et al.  TSG-14, a tumor necrosis factor- and IL-1-inducible protein, is a novel member of the pentaxin family of acute phase proteins. , 1993, Journal of immunology.

[22]  M. Rocchi,et al.  Interleukin-1-inducible genes in endothelial cells. Cloning of a new gene related to C-reactive protein and serum amyloid P component. , 1992, The Journal of biological chemistry.

[23]  Y. Watanabe,et al.  Enhanced resistance against Listeria monocytogenes at an early phase of primary infection in pregnant mice: activation of macrophages during pregnancy , 1986, Infection and immunity.

[24]  M. Pepys,et al.  Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. , 1983, Advances in immunology.

[25]  A. Schaffner,et al.  Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. , 1982, The Journal of clinical investigation.